Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis

AUTOR(ES)

Fernandez-Fresnedo, Gema

FONTE

American Society of Nephrology

RESUMO

Background and objectives: Isolated case reports have shown a beneficial effect of rituximab on pediatric patients with primary FSGS, but there is no information about rituximab treatment of FSGS in adults.

Documentos Relacionados

• Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.
• Cyclophosphamide in the treatment of focal segmental glomerulosclerosis
• A drug target for focal segmental glomerulosclerosis
• Vitamin D and gonadal steroid-resistant New World primate cells express an intracellular protein which competes with the estrogen receptor for binding to the estrogen response element.
• Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic Syndrome